ABSTRACT
Background Households are specific transmission settings, as they involve close and repeated contacts between individuals of different generations. Household surveys provide a unique opportunity to better understand SARS-CoV-2 transmission and the role of individual characteristics.
Here, we assessed the risk of SARS-CoV-2 acquisition from household and community exposure according to age, family ties, and socioeconomic and living conditions using data from the nationwide population-based EpiCov cohort/ORCHESTRA collaboration in November-December 2020.
Methods A history of SARS-CoV-2 infection was defined by a positive Euroimmun Anti-SARS-CoV-2 ELISA IgG result in November-December 2020. We applied stochastic chain binomial models fitted to the final distribution of infections in households to data from 17,983 individuals ≥5 years enrolled from 8,165 households. Models estimated the competing risks of being infected from community and household exposure.
Results Young adults aged 18-24 years had the highest risk of extra-household infection (8.9%, [95% credible interval, Crl]: 7.5 – 10.4), whereas the oldest (>75) and the youngest (6-10) had the lowest risk, 2.6% (1.8 – 3.5) and 3.4% (1.9 – 5.2), respectively. Extra-household infection was also independently associated with socioeconomic conditions. Within households, the probability of person-to-person transmission increased with age: 10.6% (5.0 – 17.9) among 6-10-year-olds to 43.1% (32.6 – 53.2) among 65-74-year-olds. It was higher between partners 29.9% (25.6 - 34.3) and from mother to child 29.1% (21.4 – 37.3) than between individuals related by other family ties.
Conclusion In 2020 in France, the main factors identified for extra-household infection were age and socioeconomic conditions. Intra-household infection mainly depended on age and family ties.
Key Messages
Young adults aged 18-24 years had the highest probability of extra-household SARS-Cov-2 acquisition over the year 2020: 8.9%, 95% credible interval (95%Crl) 7.5 – 10.4.
The probability of extra-household infection increased with family income and population density in the municipality of residence and was higher in the French regions most affected by the waves of SARS-CoV-2.
When estimating the probability of person-to-person transmission of SARS-CoV-2, the 65-74 year-olds had the highest susceptibility, i.e. the highest probability of SARS-CoV-2 acquisition when exposed to an infected household member (22.1%, 16.4 – 28.2)
The probability of transmission was the highest between partners (29.9%, 25.6 – 34.3). The probability of transmission was higher from mother to child than from father to child: 29.1%, (21.4 – 37.3) and 14.0% (5.9 – 22.8), respectively. The probability of transmission from child to parent was higher from children <12 years than for older children: 11.8% (2.5 – 25.1) and 4.1% (0.9 – 9.0), respectively.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by research grants from Inserm (Institut National de la Sante et de la Recherche Medicale), the French Ministry for Research, Drees-Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques, and the French Ministry for Health and by the Region Ile-de-France. This project has also received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 101016167, ORCHESTRA (Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic). S.N was funded by ORCHESTRA.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The CNIL (the French data protection authority) (MLD/MFI/AR205138) and the local ethics committee (Comite de Protection des Personnes Sud Mediteranee III 2020-A01191-38) gave ethical approval for this work. The survey was also reviewed by the Comite du Label de la Statistique Publique. The serological results were sent to the participants by post with information on how to interpret the individual test results.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Anonymous aggregated data for the first round are available online. The EpiCov dataset is available for research purpose concerning the first round, and will be available by March 2022 concerning the second round for research purpose on CASD (https://www.casd.eu/) after submission to approval of French Ethics and Regulatory Committee procedure (Comite du Secret Statistique, CESREES and CNIL). Access to anonymized individual data underlying the findings may be available before the planned period, on request to the corresponding author, to be submitted to approval of ethics and reglementary Committee for researchers who meet the criteria for access to data.
